These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 18946840)

  • 1. Advances in protein therapeutics.
    Woodnutt G; Violand B; North M
    Curr Opin Drug Discov Devel; 2008 Nov; 11(6):754-61. PubMed ID: 18946840
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biopharmaceutical drug discovery using novel protein scaffolds.
    Gill DS; Damle NK
    Curr Opin Biotechnol; 2006 Dec; 17(6):653-8. PubMed ID: 17055245
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bioengineering approaches to controlled protein delivery.
    Kobsa S; Saltzman WM
    Pediatr Res; 2008 May; 63(5):513-9. PubMed ID: 18427296
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of protein therapeutics by mass spectrometry: recent developments and future directions.
    Chen G; Warrack BM; Goodenough AK; Wei H; Wang-Iverson DB; Tymiak AA
    Drug Discov Today; 2011 Jan; 16(1-2):58-64. PubMed ID: 21093608
    [TBL] [Abstract][Full Text] [Related]  

  • 5. NMR metabolomics and drug discovery.
    Powers R
    Magn Reson Chem; 2009 Dec; 47 Suppl 1():S2-11. PubMed ID: 19504464
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Advancing protein therapeutics: current challenges in protein therapeutics -- CHI's Second Annual Conference.
    He M
    IDrugs; 2006 Mar; 9(3):177-8. PubMed ID: 16523380
    [No Abstract]   [Full Text] [Related]  

  • 7. Engineered protein scaffolds as next-generation antibody therapeutics.
    Gebauer M; Skerra A
    Curr Opin Chem Biol; 2009 Jun; 13(3):245-55. PubMed ID: 19501012
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fusion-proteins as biopharmaceuticals--applications and challenges.
    Schmidt SR
    Curr Opin Drug Discov Devel; 2009 Mar; 12(2):284-95. PubMed ID: 19333874
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Exploiting directed evolution for the discovery of biologicals.
    Douthwaite J; Jermutus L
    Curr Opin Drug Discov Devel; 2006 Mar; 9(2):269-75. PubMed ID: 16566297
    [TBL] [Abstract][Full Text] [Related]  

  • 10. DARPins: a new generation of protein therapeutics.
    Stumpp MT; Binz HK; Amstutz P
    Drug Discov Today; 2008 Aug; 13(15-16):695-701. PubMed ID: 18621567
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Databases of protein-protein interactions and their use in drug discovery.
    Fuentes G; Oyarzabal J; Rojas AM
    Curr Opin Drug Discov Devel; 2009 May; 12(3):358-66. PubMed ID: 19396737
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Longer action means better drug: tuning up protein therapeutics.
    Szlachcic A; Zakrzewska M; Otlewski J
    Biotechnol Adv; 2011; 29(4):436-41. PubMed ID: 21443940
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Peptoids as potential therapeutics.
    Zuckermann RN; Kodadek T
    Curr Opin Mol Ther; 2009 Jun; 11(3):299-307. PubMed ID: 19479663
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Minimizing the immunogenicity of protein therapeutics.
    Chirino AJ; Ary ML; Marshall SA
    Drug Discov Today; 2004 Jan; 9(2):82-90. PubMed ID: 15012932
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recent advances in the development of novel protein scaffolds based therapeutics.
    Azhar A; Ahmad E; Zia Q; Rauf MA; Owais M; Ashraf GM
    Int J Biol Macromol; 2017 Sep; 102():630-641. PubMed ID: 28412342
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protein splicing: A versatile tool for drug discovery.
    Cheriyan M; Perler FB
    Adv Drug Deliv Rev; 2009 Sep; 61(11):899-907. PubMed ID: 19442693
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gene expression profiling in drug discovery and development.
    Stratowa C; Wilgenbus KK
    Curr Opin Mol Ther; 1999 Dec; 1(6):671-9. PubMed ID: 19629863
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recent developments in engineering and delivery of protein and antibody therapeutics.
    Fernández LÁ; Muyldermans S
    Curr Opin Biotechnol; 2011 Dec; 22(6):839-42. PubMed ID: 21862312
    [No Abstract]   [Full Text] [Related]  

  • 19. Layered double hydroxide nanoparticles in gene and drug delivery.
    Ladewig K; Xu ZP; Lu GQ
    Expert Opin Drug Deliv; 2009 Sep; 6(9):907-22. PubMed ID: 19686052
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predicting druggable binding sites at the protein-protein interface.
    Fuller JC; Burgoyne NJ; Jackson RM
    Drug Discov Today; 2009 Feb; 14(3-4):155-61. PubMed ID: 19041415
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.